Regulations.gov document
Guidance for Industry; Recommendations To Reduce the Risk of Transmission of Disease…
Notice · FDA-2024-D-3863 · posted Feb 3, 2025
Key facts
| Document ID | FDA-2024-D-3863-0144 |
|---|---|
| Title | Guidance for Industry; Recommendations To Reduce the Risk of Transmission of Disease Agents Associated With Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products; Recommendations To Reduce the Risk of Transmission of Mycobacterium Tuberculosis by Human Cells, Tissues, and Cellular and Tissue-Based Products |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2024-D-3863 |
| Posted | Feb 3, 2025 |
| Federal Register citation | 90 FR 8802 |
| FR document number | 2025-02167 |
| Comment period opens | Feb 3, 2025 |
| Effective date | Feb 3, 2025 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: